Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4437 (113th)

Generic Drug Pricing Fairness Act

referredUnited States· United States Congress· EN

Introduced

9 April 2014

Last action

11 April 2014 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Collins, Doug [R-GA-9], Rep. Loebsack, David [D-IA-2], Rep. Scott, Austin [R-GA-8], Rep. Barton, Joe [R-TX-6], Rep. Bishop, Sanford D. [D-GA-2], Rep. Coffman, Mike [R-CO-6], Rep. Young, Don [R-AK-At Large], Rep. Southerland, Steve II [R-FL-2], Rep. Duncan, John J., Jr. [R-TN-2], Rep. Fortenberry, Jeff [R-NE-1], Rep. Williams, Roger [R-TX-25], Rep. Crawford, Eric A. "Rick" [R-AR-1], Rep. Fattah, Chaka [D-PA-2], Rep. Barletta, Lou [R-PA-11], Rep. Hanna, Richard L. [R-NY-22]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Generic Drug Pricing Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each contract entered into with a prescription drug plan (PDP) sponsor with respect to a PDP the sponsor offers to prohibit the PDP from entering into a contract with any pharmacy benefits manager (PBM) to manage the prescription drug coverage provided under such plan, or to control the costs of the prescription drug coverage under it, unless the PBM adheres to specified criteria when handling personally identifiable utilization and claims data or other sensitive patient data. Revises requirements for contracts with PDP sponsors to require that the PDP sponsor disclose to applicable pharmacies the sources used for making any update of the prescription drug pricing standard, and if the source for such a standard is not publicly available, disclose to such pharmacies all individual drug prices to be so updated in advance of their use for the reimbursement of claims. Requires the PDP sponsor, as well, to establish a process to appeal, investigate, and resolve disputes regarding individual drug prices that are less than the pharmacy acquisition price for a drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 April 2014

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 9 April 2014

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 9 April 2014

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 11 April 2014

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 9 April 2014

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 9 April 2014

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 9 April 2014

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.